Serina Therapeutics, Inc. (SER)

Serina Therapeutics Revenue

In the year 2025, Serina Therapeutics had annual revenue of $130.00K with 132.14% growth.

• Revenue (ttm): $130.00K
• Revenue Growth: +132.14%
• P/S Ratio: 172.11
• Revenue / Employee: $10,000
• Employees: 13
• Market Cap: 22.37M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	130.00K	74.00K	132.14%
Dec 31, 2024	56.00K	-3.10M	-98.22%
Dec 31, 2023	3.15M	3.12M	9,173.53%
Dec 31, 2022	34.00K	-110.00K	-76.39%
Dec 31, 2021	144.00K	-217.00K	-60.11%
Dec 31, 2020	361.00K	-1.37M	-79.11%
Dec 31, 2019	1.73M	332.00K	23.78%
Dec 31, 2018	1.40M	-8.00K	-0.57%
Dec 31, 2017	1.40M	-	-

Data Source: Fiscal.ai Last updated: Mar 25, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 1, 2026

Data Sources Report a data error